[BrightInsight in Forbes] The CIO’s ‘build versus buy’ conundrum is now ‘build versus build’
Early on during medtech and biopharma’s journey into digital innovation, many technology conversations centered on “build versus buy” and whether developing underlying technology in-house or partnering to adopt an existing platform would deliver greater efficiency, functionality and return on investment. Read...
Read More